Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company
Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company
Home > Investor Relations > Corporate Governance > Insider Transactions

Insider TransactionsSpectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company

Date Name Title Type Shares Traded Price Range
Apr 20, 2013 allen lee f md phd Officer Statement of Ownership 0 n/a
Apr 20, 2013 turgeon joseph w. Officer Statement of Ownership 0 n/a
Mar 5, 2013 maida anthony e iii Director Automatic Sell 5,000 11.50
Mar 5, 2013 maida anthony e iii Director Option Execute 5,000 3.92
Feb 5, 2013 maida anthony e iii Director Automatic Sell 5,000 12.25
Feb 5, 2013 maida anthony e iii Director Option Execute 5,000 3.92 - 4.26
Jan 3, 2013 shrotriya rajesh c md Officer Disposition (Non Open Market) 23,344 11.66
Jan 2, 2013 maida anthony e iii Director Automatic Sell 5,000 11.42
Jan 2, 2013 maida anthony e iii Director Option Execute 5,000 4.26
Dec 31, 2012 shrotriya rajesh c md Officer Sell 205,836 11.24
Dec 28, 2012 shrotriya rajesh c md Officer Sell 172,507 11.35
Dec 19, 2012 arora krishan k Director Acquisition (Non Open Market) 10,000 11.34
Dec 19, 2012 gagnon gilles Director Acquisition (Non Open Market) 10,000 11.34
Dec 19, 2012 gueth anton Director Acquisition (Non Open Market) 10,000 11.34
Dec 19, 2012 krassner stuart mitchell Director Acquisition (Non Open Market) 10,000 11.34
Dec 19, 2012 lenaz luigi md Director Acquisition (Non Open Market) 10,000 11.34
Dec 19, 2012 lenaz luigi md Director Disposition (Non Open Market) 2,800 11.34
Dec 19, 2012 maida anthony e iii Director Acquisition (Non Open Market) 10,000 11.34
Dec 19, 2012 maida anthony e iii Director Disposition (Non Open Market) 4,700 11.34
Dec 19, 2012 shrotriya rajesh c md Officer Acquisition (Non Open Market) 163,139 11.34
Showing 1-20 of 124 transactions Page: 1 2 3 4 5 6 7  See Next 20

Stock transaction information provided by EDGAR Online. Spectrum Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.

Back to top

 Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company

NASDAQ: SPPISpectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company

Price:
8.43
Change:
+ 0.30
Day High:
8.81
Day Low:
8.07
Volume:
2,438,100
4:00 PM ET on May 22, 2013
Delayed at least 20 minutes.
Provided by eSignal.

Shareholder ToolsSpectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company

Print Email

Search IRSpectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company